• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Suzi Ring

Stay informed with Suzi Ring’s coverage and analysis.

Woman with cereal
Health
The hugely popular weight-loss drugs including Ozempic may cause suicidal thoughts. Europe is investigating
By Suzi Ring and BloombergJuly 10, 2023
AstraZeneca finds its COVID booster delivers adequate protection against Omicron
Health
AstraZeneca finds its COVID booster delivers adequate protection against Omicron
By Suzi Ring and BloombergDecember 23, 2021
More than three in five pregnant women in the U.S.  are unvaccinated, putting them at risk from the fast-spreading Omicron variant
Health
More than three in five pregnant women in the U.S. are unvaccinated, putting them at risk from the fast-spreading Omicron variant
By Suzi Ring and BloombergDecember 23, 2021
Moderna says its COVID-19 booster vaccine delivers a massive increase in antibodies
Health
Moderna says its COVID-19 booster vaccine delivers a massive increase in antibodies
By Suzi Ring, Naomi Kresge and BloombergDecember 20, 2021
Pfizer-BioNTech and Moderna jabs perform best in study of COVID booster vaccines
Health
Pfizer-BioNTech and Moderna jabs perform best in study of COVID booster vaccines
By Suzi Ring, Irina Anghel and BloombergDecember 3, 2021
Vaccinated people can also spread the Delta variant, a yearlong U.K. study shows
Health
Vaccinated people can also spread the Delta variant, a yearlong U.K. study shows
By Suzi Ring and BloombergOctober 28, 2021
COVID-19 cases surge in schools as U.K. waits to offer vaccines to adolescents
Health
COVID-19 cases surge in schools as U.K. waits to offer vaccines to adolescents
By Suzi Ring, James Paton and BloombergOctober 19, 2021
AstraZeneca says antibody drug is effective at stopping mild COVID-19 from worsening
Health
AstraZeneca says antibody drug is effective at stopping mild COVID-19 from worsening
By Suzi Ring and BloombergOctober 11, 2021
AstraZeneca aims to finally gain FDA approval of its COVID vaccine this fall
Health
AstraZeneca aims to finally gain FDA approval of its COVID vaccine this fall
By Suzi Ring, Anna Edwards and BloombergJuly 29, 2021
Most young people don’t need to worry about COVID-19, major study finds
Health
Most young people don’t need to worry about COVID-19, major study finds
By Katharine Gemmell, Suzi Ring and BloombergJuly 9, 2021
Glaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s
Health
Glaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s
By Suzi Ring and BloombergJuly 2, 2021
The EU is finalizing a deal with Valneva to purchase its COVID-19 vaccine
Health
The EU is finalizing a deal with Valneva to purchase its COVID-19 vaccine
By Alberto Nardelli, Suzi Ring and BloombergJune 30, 2021
Johnson & Johnson one-shot COVID jab wins U.K. approval
Health
Johnson & Johnson one-shot COVID jab wins U.K. approval
By Suzi Ring and BloombergMay 28, 2021
AstraZeneca seeks FDA emergency approval after missing target
Health
AstraZeneca seeks FDA emergency approval after missing target
By Suzi Ring and BloombergApril 30, 2021
Promising COVID-19 antibody therapy significantly reduces risk of hospitalization, death
Health
Promising COVID-19 antibody therapy significantly reduces risk of hospitalization, death
By Suzi Ring and BloombergMarch 12, 2021
1
  • 1
  • 2
2
Most Popular
Economy
How Scott Bessent used financial engineering to finance the $2 trillion deficit while leaving it untouched—and created a $1.45 trillion shortfallplaceholder alt text
By Eva RoytburgAugust 8, 2026
Real Estate
Meet the 33-year-old CEO betting on boomers chasing their grandkids—and millennials selling their first houseplaceholder alt text
By Nick LichtenbergAugust 8, 2026
Real Estate
The tables have turned: Florida and Texas are the biggest losers in the housing market as Ohio emerges a surprise winnerplaceholder alt text
By Sydney LakeAugust 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.